|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7709001B2
(en)
*
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
EP3311836A1
(en)
|
2005-04-08 |
2018-04-25 |
Wyeth LLC |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
WO2007127668A2
(en)
*
|
2006-04-26 |
2007-11-08 |
Wyeth |
Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
|
CN101663327B
(zh)
|
2007-03-23 |
2014-05-07 |
惠氏公司 |
产生肺炎链球菌(streptococcus pneumoniae)荚膜多糖的缩短的纯化方法
|
|
EP2262480B1
(en)
*
|
2008-03-04 |
2018-02-14 |
Liquidia Technologies, Inc. |
Immunomodulator particles
|
|
JP5666310B2
(ja)
*
|
2008-12-03 |
2015-02-12 |
株式会社カネカ |
ホルミル基含有多孔質担体、それを用いた吸着体、およびそれらの製造方法
|
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
BRPI0922981A8
(pt)
|
2008-12-18 |
2019-11-26 |
Wyeth Llc |
método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae
|
|
ES2749952T3
(es)
|
2008-12-18 |
2020-03-24 |
Wyeth Llc |
Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
|
|
EP3017826A1
(en)
|
2009-03-24 |
2016-05-11 |
Novartis AG |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
|
EP2411048B1
(en)
|
2009-03-24 |
2020-05-06 |
GlaxoSmithKline Biologicals SA |
Adjuvanting meningococcal factor h binding protein
|
|
US20120052088A1
(en)
|
2009-04-30 |
2012-03-01 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
CN102939105B
(zh)
|
2009-12-22 |
2016-11-16 |
赛诺菲巴斯德有限公司 |
免疫原性组合物和相关的方法
|
|
EP2538969A4
(en)
*
|
2010-02-22 |
2013-11-27 |
Liquidia Technologies Inc |
VACCINES FROM POLYSACCHARIDE PARTICLES
|
|
CN101785857B
(zh)
*
|
2010-03-05 |
2012-09-26 |
成都安特金生物技术有限公司 |
一种新的肺炎球菌结合疫苗及其制备方法
|
|
CA2798739A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
PL2575870T3
(pl)
|
2010-06-04 |
2017-05-31 |
Wyeth Llc |
Preparaty szczepionek
|
|
AU2011268507B2
(en)
|
2010-06-25 |
2014-08-14 |
Novartis Ag |
Combinations of meningococcal factor H binding proteins
|
|
CN102462839B
(zh)
*
|
2010-11-12 |
2016-03-30 |
北京生物制品研究所 |
多糖结合疫苗及其制备方法
|
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
KR101315599B1
(ko)
|
2011-10-25 |
2013-10-10 |
건국대학교 산학협력단 |
폐렴균점막다당질 유형14 （ｃｐｓ１４）와 호스래디시 퍼옥시다제의 당단백중합체
|
|
JP2015505309A
(ja)
|
2011-12-29 |
2015-02-19 |
ノバルティス アーゲー |
髄膜炎菌ｈ因子結合タンパク質のアジュバントされた組み合わせ
|
|
JP2015510872A
(ja)
|
2012-03-07 |
2015-04-13 |
ノバルティス アーゲー |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
|
|
EP2822584A1
(en)
|
2012-03-08 |
2015-01-14 |
Novartis AG |
Combination vaccines with tlr4 agonists
|
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
JP6324961B2
(ja)
|
2012-09-06 |
2018-05-16 |
ノバルティス アーゲー |
血清群ｂ髄膜炎菌とｄ／ｔ／ｐとの組み合わせワクチン
|
|
RU2606022C2
(ru)
*
|
2012-09-07 |
2017-01-10 |
Ск Кемикалс Ко., Лтд. |
Способ получения капсульного полисахарида с пневмококковым серотипом
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
US20150320852A1
(en)
|
2012-12-18 |
2015-11-12 |
Glaxosmithkline Biologicals Sa |
Conjugates for protecting against diphtheria and/or tetanus
|
|
JP6502262B2
(ja)
|
2012-12-20 |
2019-04-17 |
ファイザー・インク |
糖複合化方法
|
|
US9782468B2
(en)
*
|
2013-05-20 |
2017-10-10 |
Shantha Biotechnics Private Limited |
Purification of polysaccharide protein conjugates
|
|
WO2015073831A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Liquidia Technologies, Inc. |
Virtual conjugate particles
|
|
CN110859957B
(zh)
|
2014-01-21 |
2024-04-12 |
辉瑞公司 |
包含缀合荚膜糖抗原的免疫原性组合物及其用途
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
BR112016015835B1
(pt)
|
2014-01-21 |
2023-12-26 |
Pfizer Inc |
Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
|
|
PL3096786T3
(pl)
|
2014-01-21 |
2021-11-08 |
Pfizer Inc. |
Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty
|
|
CN104069504B
(zh)
|
2014-05-11 |
2019-09-24 |
江苏康泰生物医学技术有限公司 |
一种增强多糖蛋白结合物免疫原性的方法
|
|
EP2987408A1
(en)
*
|
2014-08-20 |
2016-02-24 |
National University of Ireland, Galway |
Iodophor composition with improved stability in the presence of organic material
|
|
HUE062499T2
(hu)
|
2015-01-15 |
2023-11-28 |
Pfizer |
Pneumococcus-vakcinákban történõ alkalmazásra szolgáló immunogén készítmények
|
|
MY182282A
(en)
*
|
2015-05-04 |
2021-01-18 |
Pfizer |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
US11147863B2
(en)
|
2015-06-23 |
2021-10-19 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine
|
|
CN106109486A
(zh)
*
|
2015-07-06 |
2016-11-16 |
北京科兴中维生物技术有限公司 |
一种组合物及其制备方法与应用
|
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
EP3359188A1
(en)
|
2015-10-07 |
2018-08-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Streptococcus suis polysaccharide-protein conjugate composition
|
|
JP6884145B2
(ja)
|
2015-11-20 |
2021-06-09 |
ファイザー・インク |
肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
|
|
EP3436061A4
(en)
*
|
2016-03-31 |
2019-12-04 |
Liffey Biotech Limited |
Saccharide-polypeptide-conjugate compositions and methods of use thereof
|
|
CA3031797A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
CA3031799A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
NZ752348A
(en)
|
2016-09-30 |
2022-11-25 |
Biological E Ltd |
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
|
|
WO2018080213A1
(ko)
*
|
2016-10-28 |
2018-05-03 |
주식회사 엘지화학 |
향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
CN110366428B
(zh)
|
2016-12-30 |
2024-05-17 |
Vaxcyte公司 |
具有非天然氨基酸的多肽-抗原缀合物
|
|
BR112019014833A2
(pt)
|
2017-01-20 |
2020-04-14 |
Pfizer |
composições imunogênicas para uso em vacinas pneumococais
|
|
EP4656208A3
(en)
|
2017-01-31 |
2026-03-04 |
Merck Sharp & Dohme LLC |
Methods for making polysaccharide-protein conjugates
|
|
CA3052621A1
(en)
|
2017-02-03 |
2018-08-09 |
Schadeck, Eva Barbara |
Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
|
|
US11400162B2
(en)
*
|
2017-02-24 |
2022-08-02 |
Merck Sharp & Dohme Llc |
Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
|
|
JP7680185B2
(ja)
*
|
2017-02-24 |
2025-05-20 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強
|
|
WO2018227177A1
(en)
*
|
2017-06-10 |
2018-12-13 |
Inventprise, Llc |
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
WO2019043245A1
(en)
*
|
2017-09-04 |
2019-03-07 |
London School Of Hygiene And Tropical Medicine |
MICROBIAL CELLS EXPRESSING STREPTOCOCCAL SERROTYPES
|
|
MX394767B
(es)
|
2017-09-07 |
2025-03-24 |
Merck Sharp & Dohme Llc |
Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
|
|
MX394768B
(es)
*
|
2017-09-07 |
2025-03-21 |
Merck Sharp & Dohme Llc |
Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
|
|
MX2020002558A
(es)
*
|
2017-09-07 |
2020-07-13 |
Merck Sharp & Dohme |
Procesos para la formulacion de polisacaridos neumococicos para la conjugacion a una proteina transportadora.
|
|
CN111093650B
(zh)
|
2017-09-07 |
2024-03-01 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
WO2019070994A1
(en)
|
2017-10-04 |
2019-04-11 |
Liffey Biotech Limited |
SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
|
|
ES3058336T3
(es)
|
2017-12-06 |
2026-03-10 |
Merck Sharp & Dohme Llc |
Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos
|
|
BR112020014978A2
(pt)
*
|
2018-02-05 |
2020-12-22 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
EP3749357A4
(en)
|
2018-02-05 |
2022-04-20 |
Sanofi Pasteur, Inc. |
POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE COMPOSITION
|
|
US11951162B2
(en)
|
2018-04-18 |
2024-04-09 |
Sk Bioscience Co., Ltd. |
Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
|
|
US12144855B2
(en)
|
2018-04-30 |
2024-11-19 |
Merck Sharp & Dohme Llc |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
EP3787673A4
(en)
*
|
2018-04-30 |
2022-04-27 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
EP3788143B1
(en)
|
2018-04-30 |
2023-06-28 |
Merck Sharp & Dohme LLC |
Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
DK3817775T3
(da)
|
2018-07-04 |
2024-09-16 |
Vaxcyte Inc |
Forbedringer i immunogene konjugater
|
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
IL284349B2
(en)
|
2018-10-12 |
2025-06-01 |
Biological E Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine
|
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
|
CR20210333A
(es)
|
2018-12-19 |
2021-08-18 |
Merck Sharp & Dohme |
Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
|
|
WO2020208502A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
PH12022550110A1
(en)
|
2019-07-31 |
2022-12-12 |
Sk Bioscience Co Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
US20230000966A1
(en)
|
2019-11-01 |
2023-01-05 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
BR112022014555A2
(pt)
|
2020-02-23 |
2022-09-20 |
Pfizer |
Composições de escherichia coli e métodos das mesmas.
|
|
US12497640B2
(en)
*
|
2020-05-14 |
2025-12-16 |
Serum Institute Of India Private Limited |
Methods for simultaneous fragmentation and purification of bacterial polysaccharides
|
|
WO2022035816A1
(en)
|
2020-08-10 |
2022-02-17 |
Inventprise, Llc |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
|
|
KR20230056727A
(ko)
|
2020-08-26 |
2023-04-27 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
US12138302B2
(en)
|
2020-10-27 |
2024-11-12 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
PE20231934A1
(es)
|
2020-10-27 |
2023-12-01 |
Pfizer |
Composiciones de escherichia coli y metodos de las mismas
|
|
CA3200602A1
(en)
|
2020-11-04 |
2022-05-12 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
JP7804673B2
(ja)
|
2020-11-10 |
2026-01-22 |
ファイザー・インク |
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
US12357681B2
(en)
|
2020-12-23 |
2025-07-15 |
Pfizer Inc. |
E. coli FimH mutants and uses thereof
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
JP2024517780A
(ja)
|
2021-05-03 |
2024-04-23 |
ファイザー・インク |
細菌およびベータコロナウイルス感染症に対するワクチン接種
|
|
MX2023013434A
(es)
|
2021-05-28 |
2023-12-12 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos.
|
|
JP2024521847A
(ja)
|
2021-05-28 |
2024-06-04 |
ファイザー・インク |
コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
CA3247998A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions based on conjugated capsular saccharidic antigens and their uses
|
|
CA3256617A1
(en)
|
2022-05-11 |
2023-11-16 |
Pfizer Inc. |
PROCESS FOR PRODUCING VACCINE FORMULATIONS WITH PRESERVATIVES
|
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
EP4622665A2
(en)
|
2022-11-22 |
2025-10-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
AU2023403045A1
(en)
|
2022-12-01 |
2025-06-12 |
Pfizer Inc. |
Pneumococcal conjugate vaccine formulations
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
PE20252774A1
(es)
|
2023-03-30 |
2025-12-22 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
|
|
WO2024211348A1
(en)
*
|
2023-04-06 |
2024-10-10 |
Vaxcyte, Inc. |
Purification of capsular polysaccharides
|
|
AU2024255922A1
(en)
|
2023-04-14 |
2025-10-30 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
KR20260015203A
(ko)
|
2023-05-19 |
2026-02-02 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
호흡기 세포융합 바이러스 및 스트렙토코쿠스 뉴모니아에 감염에 대한 면역 반응을 유발하는 방법
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025174398A1
(en)
|
2024-02-14 |
2025-08-21 |
Merck Sharp & Dohme Llc |
26-valent pneumococcal conjugate vaccines and methods of use thereof
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2025191415A1
(en)
|
2024-03-11 |
2025-09-18 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|